Compounds, compositions and methods of using same for modulating uric acid levels

Details for Australian Patent Application No. 2009289647 (hide)

Owner Ardea Biosciences, Inc.

Inventors Gunic, Esmir; Girardet, Jean-Luc; Vernier, Jean-Michel; Tedder, Martina E.; Paisner, David A.

Agent Shelston IP

Pub. Number AU-B-2009289647

PCT Pub. Number WO2010/028190

Priority 61/180,110 20.05.09 US; 61/094,388 04.09.08 US; 12/324,764 26.11.08 US

Filing date 3 September 2009

Wipo publication date 11 March 2010

Acceptance publication date 20 September 2012

International Classifications

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 - 1,2,4-Triazoles

A61P 9/10 Drugs for disorders of the cardiovascular system

A61P 19/02 Drugs for skeletal disorders

C07D 249/10 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/12 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/028190 Priority application(s): WO2010/028190

20 September 2012 Application Accepted

  Published as AU-B-2009289647

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289649-Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

2009289646-Compounds, compositions and methods of using same for modulating uric acid levels